サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434234

アクチビンA市場：タイプ別、用途別-2024-2030年の世界予測

Activin-A Market by Type (Activin A Human, Activin A Mouse/ Rat), Application (Academic Research, Commercial Research) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アクチビンA市場：タイプ別、用途別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アクチビンA市場規模は2023年に2億6,280万米ドルと推定され、2024年には2億8,773万米ドルに達し、CAGR 9.57%で2030年には4億9,854万米ドルに達すると予測されます。

アクチビンAの世界市場

主な市場の統計
基準年[2023］ 2億6,280万米ドル
予測年[2024] 2億8,773万米ドル
予測年 [2030] 4億9,854万米ドル
CAGR（%） 9.57%
アクチビンA Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはアクチビンA市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、アクチビンA市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-アクチビンA市場の市場規模および予測は？

2-アクチビンA市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-アクチビンA市場における技術動向と規制の枠組みは？

4-アクチビンA市場における主要ベンダーの市場シェアは？

5-アクチビンA市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 細胞治療の需要の高まり
      • アクチビンAによってもたらされる中胚葉誘導、神経細胞分化、骨リモデリング、造血などの利点
    • 抑制要因
      • 製造工程のコストが高い
    • 機会
      • 幅広いサブ適応症と利用可能な薬剤標的
      • 生産プロセスのさらなる進歩
    • 課題
      • アクチビンAの摂取により起こり得る副作用
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 アクチビンA市場：タイプ別

  • アクチビンAヒト
  • アクチビンAマウス/ラット

第7章 アクチビンA市場：用途別

  • 学術調査
  • 商業調査

第8章 南北アメリカのアクチビンA市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のアクチビンA市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのアクチビンA市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Ajinomoto Co., Inc.
    • Ansh Labs, LLC
    • Bio-Techne Corporation
    • BioLegend, Inc.
    • Cell Guidance Systems LLC
    • CellGenix GmbH
    • Enzo Life Sciences, Inc.
    • Merck KGaA
    • Miltenyi Biotec, Inc.
    • PeproTech, Inc.
    • Proteintech Group Inc.
    • Qkine Ltd.
    • RayBiotech, Inc.
    • STEMCELL Technologies Inc.
    • StemRD Inc.
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ACTIVIN-A MARKET RESEARCH PROCESS
  • FIGURE 2. ACTIVIN-A MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ACTIVIN-A MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ACTIVIN-A MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ACTIVIN-A MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ACTIVIN-A MARKET DYNAMICS
  • FIGURE 7. ACTIVIN-A MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ACTIVIN-A MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ACTIVIN-A MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ACTIVIN-A MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ACTIVIN-A MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ACTIVIN-A MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ACTIVIN-A MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ACTIVIN-A MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACTIVIN-A MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ACTIVIN-A MARKET SIZE, BY ACTIVIN A HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ACTIVIN-A MARKET SIZE, BY ACTIVIN A MOUSE/ RAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. ACTIVIN-A MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ACTIVIN-A MARKET SIZE, BY COMMERCIAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ACTIVIN-A MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 98. ACTIVIN-A MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 99. ACTIVIN-A MARKET LICENSE & PRICING
目次
Product Code: MRR-035DA3C6369D

[182 Pages Report] The Activin-A Market size was estimated at USD 262.80 million in 2023 and expected to reach USD 287.73 million in 2024, at a CAGR 9.57% to reach USD 498.54 million by 2030.

Global Activin-A Market

KEY MARKET STATISTICS
Base Year [2023] USD 262.80 million
Estimated Year [2024] USD 287.73 million
Forecast Year [2030] USD 498.54 million
CAGR (%) 9.57%
Activin-A Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Activin-A Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Activin-A Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Activin-A Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Ansh Labs, LLC, Bio-Techne Corporation, BioLegend, Inc., Cell Guidance Systems LLC, CellGenix GmbH, Enzo Life Sciences, Inc., Merck KGaA, Miltenyi Biotec, Inc., PeproTech, Inc., Proteintech Group Inc., Qkine Ltd., RayBiotech, Inc., STEMCELL Technologies Inc., StemRD Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Activin-A Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Activin A Human
    • Activin A Mouse/ Rat
  • Application
    • Academic Research
    • Commercial Research
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Activin-A Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Activin-A Market?

3. What are the technology trends and regulatory frameworks in the Activin-A Market?

4. What is the market share of the leading vendors in the Activin-A Market?

5. Which modes and strategic moves are suitable for entering the Activin-A Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Activin-A Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for cell therapy
      • 5.1.1.2. Benefits provided by activin A such as mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of manufacturing process
    • 5.1.3. Opportunities
      • 5.1.3.1. Broad range of sub-indications and available drug targets
      • 5.1.3.2. Increasing advancements in the production process
    • 5.1.4. Challenges
      • 5.1.4.1. Probable side effects due to consumption of activin A
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Activin-A Market, by Type

  • 6.1. Introduction
  • 6.2. Activin A Human
  • 6.3. Activin A Mouse/ Rat

7. Activin-A Market, by Application

  • 7.1. Introduction
  • 7.2. Academic Research
  • 7.3. Commercial Research

8. Americas Activin-A Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Activin-A Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Activin-A Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Ajinomoto Co., Inc.
    • 12.1.2. Ansh Labs, LLC
    • 12.1.3. Bio-Techne Corporation
    • 12.1.4. BioLegend, Inc.
    • 12.1.5. Cell Guidance Systems LLC
    • 12.1.6. CellGenix GmbH
    • 12.1.7. Enzo Life Sciences, Inc.
    • 12.1.8. Merck KGaA
    • 12.1.9. Miltenyi Biotec, Inc.
    • 12.1.10. PeproTech, Inc.
    • 12.1.11. Proteintech Group Inc.
    • 12.1.12. Qkine Ltd.
    • 12.1.13. RayBiotech, Inc.
    • 12.1.14. STEMCELL Technologies Inc.
    • 12.1.15. StemRD Inc.
    • 12.1.16. Thermo Fisher Scientific Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing